Drugs / CD40L Fibroblasts
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00058799 | Jun 1999 → Jun 2010 | leukemia | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD40L Fibroblasts | “Leukemic Blasts 2 x 10\^7; IL-2 Fibroblasts 2 x 10\^7; CD40L Fibroblasts 2 x 10\^5” NCT00058799 ↗ |
| Modality | Cell therapy | “gene-modified CD40L and IL-2 skin fibroblasts” NCT00058799 ↗ |
| Route | Subcutaneous | “The modified fibroblasts will be injected with a number of leukemic cells under the skin.” NCT00058799 ↗ |